VHL and nonpapillary renal cell carcinoma: Heightened ferroptosis susceptibility of ccRCC due to VHL loss has been effectively exploited in preclinical models using cysteine depletion to reverse ferroptosis-inhibiting effects of BAP1 loss (131).